Back to search
FDAFDA · Food and drugs·Recall number D-0801-2018

Macroaggregated albumin (MAA) kit (for the preparation of Tc99m MAA), Aggregated and non-Aggregated Human Serum Albumin 2.5-5 mg Sodium Acetate Sol 200 mL/0.125 mL lyophilized powder in 10 mL glass vial, Rx only, AnazaoHealth, Tampa, FL

Published May 16, 2018 · Recall initiated: April 26, 2018

Summary

FDA records drug Class II recall D-0801-2018, published May 16, 2018 and initiated April 26, 2018. Recalling firm: Coast Quality Pharmacy LLC; Status: Terminated; Reported quantity: 52 vials; Lot: Lot: MAA-171219BM BUD: 4/19/18; MAA-180226BM BUD: 06/26/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Coast Quality Pharmacy LLC
Distributor
AL, CA, FL, MI, SC, TX
Lot
Lot: MAA-171219BM BUD: 4/19/18; MAA-180226BM BUD: 06/26/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Macroaggregated albumin (MAA) kit (for the preparation of Tc99m MAA), Aggregated and non-Aggregated Human Serum Albumin 2.5-5 mg Sodium Acetate Sol 200 mL/0.125 mL lyophilized powder in 10 mL glass vial, Rx only, AnazaoHealth, Tampa, FL recalled?

Yes. FDA published recall D-0801-2018 on May 16, 2018. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter